How and When to Refer Patients for Oncogenetic Counseling in the Era of PARP Inhibitors

Therapeutic Advances in Medical Oncology - United States
doi 10.1177/1758835919897530
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

SAGE Publications

Related search

Psychological Assessment of Chronic Pain Patients: When, How and Why Refer?

Revista Dor
2014English

Suspected Neurological Conditions: When to Refer

Prescriber
Pharmacology
2019English

Chronic Thromboembolic Pulmonary Hypertension: When to Suspect It, When to Refer for Surgery

Advances in Pulmonary Hypertension
2003English

Detection of Perimacular Red Dots and Blots When Screening for Diabetic Retinopathy: Refer or Not Refer?

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2018English

PARP Inhibitors in Ovarian Cancer

2013English

More Breast Cancer Patients Could Benefit From PARP Inhibitors

Cancer
Cancer ResearchOncology
2017English

The Development of PARP Inhibitors in Ovarian Cancer: From Bench to Bedside

British Journal of Cancer
Cancer ResearchOncology
2015English

The Evolving Landscape of Predictive Biomarkers of Response to PARP Inhibitors

Journal of Clinical Investigation
Medicine
2018English

Who Did What? The Roles of R Package Authors and How to Refer to Them

R Journal
UncertaintyNumerical AnalysisStatisticsProbability
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy